Cancer Genome Dynamics High-Impact Publications | NYU Langone Health

Skip to Main Content
Cancer Genome Dynamics Research Program Cancer Genome Dynamics High-Impact Publications

Cancer Genome Dynamics High-Impact Publications

Faculty in the Cancer Genome Dynamics Research Program at Perlmutter Cancer Center publish high-impact studies about genetics and cancer.

Adams S. Dramatic response of metaplastic breast cancer to chemo-immunotherapy. NPJ Breast Cancer. 2017. DOI.

Cherniack AD … Levine DA. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell. 2017. DOI.

Cimmino L … Aifantis I. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. 2017. DOI.

Hewitt SL … Skok JA. The conserved ATM kinase RAG2-S365 phosphorylation site limits cleavage events in individual cells independent of any repair defect. Cell Rep. 2017. DOI.

Kwa M … Esteva FJ. Clinical utility of gene-expression signatures in early stage breast cancer. Nat Rev Clin Oncol. 2017. DOI.

Mitchell LA … Boeke JD. Synthesis, debugging, and effects of synthetic chromosome consolidation: synVI and beyond. Science. 2017. DOI.

Richardson SM … Bader JS. Design of a synthetic yeast genome. Science. 2017. DOI.

Schneider JA and Logan SK. Revisiting the role of Wnt/beta-catenin signaling in prostate cancer. Mol Cell Endocrinol. 2017. DOI.

Stebbing J … Esteva FJ. CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial. Lancet Oncol. 2017. DOI.

Winick N … Carroll WL. Impact of initial CSF findings on outcome among patients with National Cancer Institute standard- and high-risk B-cell acute lymphoblastic leukemia: A report from the children’s oncology group. J Clin Oncol. 2017. DOI.